NEW YORK (GenomeWeb News) — The Erasmus Medical Center will use Illumina’s BeadChips in a 10,000-subject study aimed at identifying early environmental and genetic causes of abnormal growth in fetal development, Illumina said today.
 
The Rotterdam, Netherlands-based research hospital has bought Illumina’s Infinium HD Human610-Quad BeadChips for the Generation R Study, which is backed in part by the Dutch government, industry partners, and the hospital.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.